| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM980343W |
| P698 | PubMed publication ID | 9804697 |
| P50 | author | Jesus Blazquez | Q68273789 |
| P2093 | author name string | Shoichet BK | |
| Baquero F | |||
| Weston GS | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4577-4586 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase | |
| P478 | volume | 41 |
| Q95409426 | A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World |
| Q42007896 | A detergent-based assay for the detection of promiscuous inhibitors |
| Q40665387 | A genetically encoded boronate-containing amino acid |
| Q40682125 | A β-Lactamase-Imprinted Responsive Hydrogel for the Treatment of Antibiotic-Resistant Bacteria |
| Q37856761 | Aminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors |
| Q52673510 | Boric acid and boronic acids inhibition of pigeonpea urease. |
| Q27006075 | Boron chemicals in diagnosis and therapeutics |
| Q35545973 | Colloidal aggregation and the in vitro activity of traditional Chinese medicines |
| Q57696978 | Covalent Interactions in Chemosensor Design |
| Q27665021 | Design, Synthesis, Crystal Structures, and Antimicrobial Activity of Sulfonamide Boronic Acids as β-Lactamase Inhibitors |
| Q27629650 | Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases |
| Q27674310 | Fragment-guided design of subnanomolar -lactamase inhibitors active in vivo |
| Q42123019 | Functional analyses of AmpC beta-lactamase through differential stability |
| Q33231455 | High-throughput assays for promiscuous inhibitors. |
| Q44604136 | Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs |
| Q33958491 | Inhibition of class A and C beta-lactamases by diaroyl phosphates |
| Q33606363 | Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design |
| Q34102811 | Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance |
| Q33914224 | Intramolecular cooperativity in the reaction of diacyl phosphates with serine beta-lactamases |
| Q30487039 | Kinetics and mechanism of inhibition of a serine beta-lactamase by O-aryloxycarbonyl hydroxamates |
| Q47116120 | Label-free fiber optic optrode for the detection of class C β-lactamases expressed by drug resistant bacteria. |
| Q37767653 | New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance |
| Q33622976 | New β-lactamase inhibitors: a therapeutic renaissance in an MDR world |
| Q34211132 | Overcoming antimicrobial resistance by targeting resistance mechanisms |
| Q33999238 | Permeation through the cell membrane of a boron-based β-lactamase inhibitor |
| Q33856282 | Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli |
| Q37148505 | Promiscuous aggregate-based inhibitors promote enzyme unfolding |
| Q52902179 | Selectively Inducing Cancer Cell Death by Intracellular Enzyme-Instructed Self-Assembly (EISA) of Dipeptide Derivatives. |
| Q37371404 | Stable Colloidal Drug Aggregates Catch and Release Active Enzymes |
| Q42063999 | Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors |
| Q27639425 | Structural bases of stability-function tradeoffs in enzymes |
| Q27661425 | Structural study of phenyl boronic acid derivatives as AmpC β-lactamase inhibitors |
| Q36134510 | Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors. |
| Q27632621 | Structure-based design and in-parallel synthesis of inhibitors of AmpC beta-lactamase |
| Q60195800 | Structure-based discovery and in-parallel optimization of novelcompetitive inhibitors of thymidylate synthase |
| Q41874068 | Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell culture |
| Q27649007 | Structure-based optimization of cephalothin-analogue boronic acids as β-lactamase inhibitors |
| Q42594369 | Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures |
| Q57696998 | Synthetic Lectin Mimics Artificial Carbohydrate Receptors |
| Q34568935 | The bacterial cell wall as a source of antibacterial targets |
| Q27620652 | The complexed structure and antimicrobial activity of a non-β-lactam inhibitor of AmpC β-lactamase |
| Q24646623 | Three decades of beta-lactamase inhibitors |
| Q64327308 | Using Fragment-Based Approaches to Discover New Antibiotics |
Search more.